Author

J. Wongvipat

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Choi· 2 shared E. Lee· 2 shared A. C. A. Rivera· 1 shared A. Gopalan· 1 shared C. L. Sawyers· 1 shared C. Sawyers· 1 shared C.-C. Chen· 1 shared D. Zheng· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Choi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer

E. Lee, Z. Zhang, C.-C. Chen, D. Choi, A. C. A. Rivera, E. Linton, Y.-j. Ho, J. Love, J. LaClair, J. Wongvipat, C. Sawyers

This study shows that treatment timing affects the path to androgen receptor signaling inhibitor resistance in prostate cancer, with resistance arising through different mechanisms depending on the tumor context.

bioRxiv · Mar 18, 2024 · PreprintCancer Biology

GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance

C. L. Sawyers, E. Lee, J. Wongvipat, D. Choi, P. Wang, D. Zheng, P. A. Watson, A. Gopalan

This study identifies GREB1 as a driver of antiandrogen resistance in prostate cancer by amplifying androgen receptor output through enhanced DNA binding and p300 recruitment.

bioRxiv · Oct 2, 2018Cancer Biology